VANCOUVER, BC / ACCESS Newswire / January 29, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce positive interim resu ...

VANCOUVER, BC / ACCESS Newswire / January 29, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, ...

Compounded semaglutide - the active ingredient in the blockbuster drugs mixed with other additives - is produced by ...

Ozempic isn’t the only drug that mimics the natural GLP-1 hormone, so users feel fuller for longer and eat less. There’s also Zepbound, Mounjaro, Trulicity and Victoza — and many more on the horizon ...

Before Canada decides to rely on foreign drug regulators to approve new medicines, Health Canada needs to show that it will ...

Agency updates guidance after increase in reports of condition to the yellow card scheme ...

Poison control calls involving GLP-1 medications like semaglutide and tirzepatide have dramatically risen in recent years.

Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual ...

THE gut microbiome was shown to predict how well patients with Type 2 diabetes responded to newer glucose-lowering therapies ...

The global demand for effective obesity treatments has been surging, with a market size projected to reach USD 60.53 billion ...

With the stock's last traded price at Rs 1,597.60, Sun Pharmaceutical Industries experienced a decline of 0.81% amid a surge in trading volume.

The SURPASS-2 trial compared three doses of tirzepatide (5 mg, 10 mg, 15 mg) with semaglutide 1 mg, in adults with type 2 diabetes who were already taking metformin. The primary aim was ...